Info Sheets , Solubility Enhancement , Drug Product

How to Address Poor Solubility: A Data-Driven Path to Success (Infographic)

25 September 2026
Overview

Poor solubility can create significant uncertainty in both clinical performance and formulation strategy. An evidence-led approach can help you evaluate options, reduce development risk, and advance the right formulation with confidence.

Our latest infographic outlines a practical, evidence-led framework for making smarter solubility decisions throughout development. Learn how to understand the molecule, preserve credible formulation options, and use human pharmacokinetic (PK) data to guide critical development decisions. 

We also highlight real examples demonstrating how different programs can require different approaches, from simple formulations that achieve clinical objectives to enabling technologies that deliver meaningful improvements in exposure.

Download
Date
25 September 2026
Ask The Experts

Solubility enhancement questions? Get answers from our team.

Have a question about your poorly soluble molecule? Ask a member of our team about our capabilities for drug product formulation, clinical or commercial manufacturing to keep your drug program on-track.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Asma Patel

VP, Global Commercial and Scientific Consulting - Drug Product

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert
Brad Rowe

Senior Director, Integrated Development

Brad Rowe joined the organization in 2005 and is based from our Philadelphia, PA sites in Garnet Valley and Boothwyn. He joined QS...

About Brad
Get in touch
Humanity can't afford to wait, so neither can we.